Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 12NIH 3INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 473Neoplasms 290Breast Neoplasms 277Colorectal Neoplasms 223Neoplasm Metastasis 187Prostatic Neoplasms 168Ovarian Neoplasms 163Lung Neoplasms 154Multiple Myeloma 152Recurrence 132Melanoma 116Pancreatic Neoplasms 114Squamous Cell Carcinoma of Head and Neck 104Endometrial Neoplasms 98Stomach Neoplasms 97Leukemia, Myeloid, Acute 95Small Cell Lung Carcinoma 84Leukemia, Lymphocytic, Chronic, B-Cell 83Lymphoma, Non-Hodgkin 81Triple Negative Breast Neoplasms 80Carcinoma, Renal Cell 79Carcinoma, Hepatocellular 77Urinary Bladder Neoplasms 75Lymphoma, Large B-Cell, Diffuse 72Lymphoma, Follicular 64Advanced Solid Tumors 63Lymphoma 60Glioblastoma 57Parkinson Disease 4, Autosomal Dominant Lewy Body 55Head and Neck Neoplasms 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Barrett Esophagus × 90 days × Clear all
NCT03311451 2026-05-22

C2 CryoBalloonâ„¢ 180 Ablation System Dose De-escalation Study.

Merit Medical Systems, Inc.

Phase NA Active not recruiting
62 enrolled
Gastrointestinal

Barrett Esophagus

NCT04312633 2026-03-20

Clinical Utility of WATS3D: A 5-Year Prospective Study

CDx Diagnostics

Recruiting
90,000 enrolled
Gastrointestinal

Barrett Esophagus, Esophageal Diseases, Gastroesophageal Reflux

NCT06803927 2026-03-18

DETECT-ME

Cyted Health Inc

Recruiting
700 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡